Literature DB >> 15935129

Hallucinations in the general population.

Louise C Johns1.   

Abstract

Although hallucinations occur in a range of organic and psychiatric conditions, they are not invariably a sign of illness and also occur in "normal" individuals. Evidence indicates that psychotic hallucinations lie on a continuum with normal experiences, and many more people experience hallucinations than meet criteria for clinical psychosis. In addition to a symptomatic continuum between normal individuals and patients with psychosis, there is evidence that hallucinatory experiences in nonclinical and clinical samples may share the same underlying etiologic influences, including sociodemographic risk factors and neurocognitive mechanisms. Predictors of patient status include beliefs about hallucinations, negative mood, and perceived lack of control.

Entities:  

Mesh:

Year:  2005        PMID: 15935129     DOI: 10.1007/s11920-005-0049-9

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  31 in total

1.  Temporal stability of the Launay-Slade Hallucination Scale for high- and low-scoring normal subjects.

Authors:  A Aleman; M R Nieuwenstein; K B Böcker; E H de Haan
Journal:  Psychol Rep       Date:  1999-12

2.  A cognitive model of the positive symptoms of psychosis.

Authors:  P A Garety; E Kuipers; D Fowler; D Freeman; P E Bebbington
Journal:  Psychol Med       Date:  2001-02       Impact factor: 7.723

3.  Occurrence of hallucinatory experiences in a community sample and ethnic variations.

Authors:  Louise C Johns; James Y Nazroo; Paul Bebbington; Elizabeth Kuipers
Journal:  Br J Psychiatry       Date:  2002-02       Impact factor: 9.319

4.  Sexual and physical abuse during childhood and adulthood as predictors of hallucinations, delusions and thought disorder.

Authors:  John Read; Kirsty Agar; Nick Argyle; Volkmar Aderhold
Journal:  Psychol Psychother       Date:  2003-03       Impact factor: 3.915

5.  Compelling imagery, unanticipated speech and deceptive memory: neurocognitive models of auditory verbal hallucinations in schizophrenia.

Authors:  Marc L Seal; Andre Aleman; Philip K McGuire
Journal:  Cogn Neuropsychiatry       Date:  2004 Feb-May       Impact factor: 1.871

6.  Evidence that three dimensions of psychosis have a distribution in the general population.

Authors:  N C Stefanis; M Hanssen; N K Smirnis; D A Avramopoulos; I K Evdokimidis; C N Stefanis; H Verdoux; J Van Os
Journal:  Psychol Med       Date:  2002-02       Impact factor: 7.723

7.  Psychotic symptoms in non-clinical populations and the continuum of psychosis.

Authors:  Hélène Verdoux; Jim van Os
Journal:  Schizophr Res       Date:  2002-03-01       Impact factor: 4.939

8.  The effects of emotional salience, cognitive effort and meta-cognitive beliefs on a reality monitoring task in hallucination-prone subjects.

Authors:  F Larøi; M Van der Linden; P Marczewski
Journal:  Br J Clin Psychol       Date:  2004-09

Review 9.  Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations.

Authors:  Daniel Freeman; Philippa A Garety
Journal:  Behav Res Ther       Date:  2003-08

10.  Cognitive and emotional predictors of predisposition to hallucinations in non-patients.

Authors:  Anthony P Morrison; Adrian Wells; Sarah Nothard
Journal:  Br J Clin Psychol       Date:  2002-09
View more
  21 in total

1.  Early intervention in psychosis: a case study on normal and pathological.

Authors:  Constantin Tranulis; Lawrence Park; Laura Delano; Byron Good
Journal:  Cult Med Psychiatry       Date:  2009-12

2.  Measurement invariance of the Spanish Launay-Slade Hallucinations Scale-Extended version between putatively healthy controls and people diagnosed with a mental disorder.

Authors:  Sara Siddi; Susana Ochoa; Aida Farreny; Gildas Brébion; Frank Larøi; Jorge Cuevas-Esteban; Josep Maria Haro; Christian Stephan-Otto; Antonio Preti
Journal:  Int J Methods Psychiatr Res       Date:  2018-09-20       Impact factor: 4.035

3.  Musical hallucinations in normal children and adult non-psychiatric population.

Authors:  Victor Aziz
Journal:  BMJ Case Rep       Date:  2009-02-02

4.  Measuring psychotic depression.

Authors:  S D Østergaard; B S Meyers; A J Flint; B H Mulsant; E M Whyte; C M Ulbricht; P Bech; A J Rothschild
Journal:  Acta Psychiatr Scand       Date:  2013-06-25       Impact factor: 6.392

5.  Auditory hallucinations in a cross-diagnostic sample of psychotic disorder patients: a descriptive, cross-sectional study.

Authors:  Ann K Shinn; Danielle Pfaff; Sarah Young; Kathryn E Lewandowski; Bruce M Cohen; Dost Öngür
Journal:  Compr Psychiatry       Date:  2011-12-22       Impact factor: 3.735

6.  Striatal abnormalities and spontaneous dyskinesias in non-clinical psychosis.

Authors:  Vijay A Mittal; Joseph M Orr; Jessica A Turner; Andrea L Pelletier; Derek J Dean; Jessica Lunsford-Avery; Tina Gupta
Journal:  Schizophr Res       Date:  2013-10-22       Impact factor: 4.939

7.  Predicting hallucination proneness based on mindfulness in university students: the mediating role of mental distress.

Authors:  Seyed Ruhollah Hosseini; Nikzad Ghanbari Pirkashani; Mahshid Zarnousheh Farahani; Sheyda Zarnousheh Farahani; Roghieh Nooripour
Journal:  Community Ment Health J       Date:  2020-05-19

8.  Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis.

Authors:  Vijay Anand Mittal; Joseph Michael Orr; Andrea Pelletier; Derek James Dean; Ashley Smith; Jessica Lunsford-Avery
Journal:  Psychiatry Res       Date:  2013-01-16       Impact factor: 3.222

9.  Orbitofrontal cortex volume and intrinsic religiosity in non-clinical psychosis.

Authors:  Andrea Pelletier-Baldelli; Derek J Dean; Jessica R Lunsford-Avery; Ashley K Smith Watts; Joseph M Orr; Tina Gupta; Zachary B Millman; Vijay A Mittal
Journal:  Psychiatry Res       Date:  2014-04-04       Impact factor: 3.222

Review 10.  Delusions in the nonclinical population.

Authors:  Daniel Freeman
Journal:  Curr Psychiatry Rep       Date:  2006-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.